Advertisement
Canada markets open in 6 hours 53 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7331
    +0.0008 (+0.11%)
     

  • CRUDE OIL

    84.00
    +0.43 (+0.51%)
     

  • Bitcoin CAD

    87,878.48
    +51.73 (+0.06%)
     

  • CMC Crypto 200

    1,391.13
    -5.40 (-0.39%)
     

  • GOLD FUTURES

    2,351.60
    +9.10 (+0.39%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,769.25
    +201.75 (+1.15%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

Company News For Jun 24, 2019

Zacks Equity Research

  • Canopy Growth Corporation’s CGC shares dipped 8.1% after the company reported that its recreational marijuana sales fell to $52.2 million in fourth quarter fiscal 2019 from $54.3 million in the previous quarter

  • CarMax, Inc.’s KMX shares gained 3.2% after the company reported first quarter fiscal 2020 earnings per share of $1.59, surpassing the Zacks Consensus Estimate of $1.49

  • Shares of Medtronic plc MDT gained 0.1% after the company raised its quarterly dividend to $0.54 a share from $0.50 earlier

  • Shares of Red Hat, Inc. RHT dipped 0.4% after the company reported first quarter 2019 earnings per share of $1, lower than the previous quarter earnings of $1.16 a share


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CarMax, Inc. (KMX) : Free Stock Analysis Report
 
Red Hat, Inc. (RHT) : Free Stock Analysis Report
 
Medtronic PLC (MDT) : Free Stock Analysis Report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research